Talaris Therapeutics to Present at the 2022 Cell & Gene Meeting on the Mesa
October 04 2022 - 7:00AM
Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage
cell therapy company developing therapies with the potential to
transform the standard of care in solid organ transplantation and
severe immune and blood disorders, today announced that Scott
Requadt, Chief Executive Officer of Talaris, will present at the
2022 Cell & Gene Meeting on the Mesa being held October 11-13,
2022 in Carlsbad, California and livestreamed globally. In
addition, members from the management team will also be in
attendance.
A pre-recorded presentation will be available on-demand starting
Tuesday, October 11, 2022. Please visit
https://meetingonthemesa.com for full information including
registration.
About Talaris TherapeuticsTalaris Therapeutics,
Inc. is a late-clinical stage cell therapy company developing
therapies with the potential to transform the standard of care in
solid organ transplantation and severe immune and blood disorders.
Talaris maintains corporate offices in Boston, MA, its cell
processing facility in Louisville, KY, and additional research
operations in Houston, TX.
Media ContactLisa RaffenspergerTen Bridge
Communicationslisa@tenbridgecommunications.com(617)
903-8783
Investor ContactChris BrinzeyICR
Westwickechris.brinzey@westwicke.com(339)
970-2843
Talaris Therapeutics (NASDAQ:TALS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Talaris Therapeutics (NASDAQ:TALS)
Historical Stock Chart
From Sep 2023 to Sep 2024